Ben Constable Email & Phone Number

Mosman, Nsw, Au

Toronto, Ontario, Ca

Lumira Ventures is a leading North American-based healthcare venture capital firm with offices in Canada, the United States, and Australia. We are a thesis-driven, impactful investor whose goal is to build transformative life science companies to deliver innovative and cost-effective products for patients and top-quartile returns for our investors. We were formed by our partners in 2007 following a management buy-out of a corporate-affiliated healthcare venture capital business that had been founded in 1989.Our investment team is deeply domain specific, and our partners have all been engaged in the industry as entrepreneurs, researchers, clinicians, academics, business development professional and investors for many years.Success stories include: Aurinia Pharmaceuticals (AUPH,nasdaq), G1 Therapeutics (GTHX,nasdaq) , Zymeworks Inc. (ZYME,nasdaq), Engage Therapeutics (acquired by UCB Pharma, Kai Pharmaceuticals (acquired by Amgen), Ception Therapeutics (acquired by Cephalon), Morphotek, (acquired by Eisai Co.), Alveolus (acquired by Merit Medical), Gauva (acquired by Millipore), Corus Pharma (acquired by Gilead Sciences), Depomed (exit following PIPE), Ista (exit following PIPE), Pharmasset (acquired by Gilead following IPO) and MAKO Surgical (acquired by Stryker following IPO).Lumira Ventures Australia aims to take advantage of what we see as an opportunity in Australia, by leveraging the unique insights and experiences we gained over the past 15 years from investing in transformative North American based healthcare and life science companies, especially those founded in Canada and select regions of the U.S. which are underserved by traditional venture capital funds. We aim to bring syndication and international connectivity to augment the local ecosystem.At Lumira Ventures Australia Ben is leading the project to establish the local fund, team and network, connecting the Australian ecosystem players to Lumira’s successful international team and resources.

AULUS Partners Services and Accelerates high potential Australian Life Sciences opportunities that are transformative for patients on a Global scale. Our firm is asked by Founders, Venture firms, Research Institutes, governments and other stakeholders to support their commercialization goals. Our main focus has been to benchmark Australian technologies against global peers and to connect the entities to functional experts and partners internationally when helpful.

Los Angeles, California, Us

ThinkCulinary is a leading importer of quality food items and is a master distributor of pasture raised craft proteins, which are primarily supplied to high-end foodservice and retail operations in the Western USA. Ben supports the Founder-CEO and team with strategy and to grow the business.

Eden Prairie, Mn, Us

MIVI is a venture and corporate-backed revenue and clinical-stage interventional neurovascular startup that aims to expand the boundaries of what is possible in treatment of ischemic stroke, by equipping physicians with the advanced tools they need to continually improve patient outcomes, even in the most challenging cases. MIVI’s lead products are the Q-Catheter, which is advancing clot aspiration in small neurovascular vessels and the DAISe, which is designed to reduce distal embolization. Since its inception, Ben has been involved in five funding rounds, positioning the company’s technology and working with senior management.

Seattle, Washington, Us

GameSight, Seattle, USA2014 – PresentInitial Investor, Advisory Board and now Mentor to the CEOGamesight is venture-backed and the #1 analytics company to the console and PC game industry. We build technology to help game developers build, understand, and grow their fanbase. We do this by empowering game companies with tools, data, and experience so they can better understand their players. We bring community, marketing, and analytics together to provide valuable insights.

Plymouth, Minnesota, Us

TissX sources, manufactures and supplies a variety of tissue products and services for the cardiac, vascular and other specialty surgical applications. We develop and manufacture products including fixed tissue pericardial patches and heart valve repair products. TissX also works with corporations to source and supply tissue, provide OEM services, and enter collaborations for the development of tissue bioprosthetics. Since its inception, Ben was involved in every commercial aspect of the business until TissX was successfully sold in 2021.

Agoura Hills, Ca, Us

Investment committee member with this California angel organization, now part of TechCoast Angels. Also an active member with ArchAngels during this period.

Melbourne, Victoria, Au

Commercializing a novel photovoltaic array technology

Life sciences consulting firm and incubator

A start-up that developed an artificial cornea

A startup commercializing a novel wavelength laser for refractive surgery

A drug development company

London, Greater London, Gb

Progressed as a corporate attorney with Freehills, a leading regional law firm, specializing in company, M&A, fundraising, and securities law, including a 12-month secondment to the head office of ASIC in 1992 to support policy and High Court submissions concerning the then recently-enacted Corporations Law (1991)

Bjuris And Llb, Law

Maicd